CA2466012A1 - Methode de determination en continu et de facon non invasive des caracteristiques physiologiques - Google Patents
Methode de determination en continu et de facon non invasive des caracteristiques physiologiques Download PDFInfo
- Publication number
- CA2466012A1 CA2466012A1 CA002466012A CA2466012A CA2466012A1 CA 2466012 A1 CA2466012 A1 CA 2466012A1 CA 002466012 A CA002466012 A CA 002466012A CA 2466012 A CA2466012 A CA 2466012A CA 2466012 A1 CA2466012 A1 CA 2466012A1
- Authority
- CA
- Canada
- Prior art keywords
- blood
- patient
- radiation
- absorbance
- log
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 126
- 210000004369 blood Anatomy 0.000 claims abstract description 245
- 239000008280 blood Substances 0.000 claims abstract description 245
- 239000000523 sample Substances 0.000 claims abstract description 216
- 238000002835 absorbance Methods 0.000 claims abstract description 130
- 230000005855 radiation Effects 0.000 claims abstract description 124
- 230000000747 cardiac effect Effects 0.000 claims abstract description 84
- 230000036772 blood pressure Effects 0.000 claims abstract description 50
- 239000000470 constituent Substances 0.000 claims abstract description 24
- 238000012544 monitoring process Methods 0.000 claims abstract description 14
- 229910052760 oxygen Inorganic materials 0.000 claims description 84
- 239000001301 oxygen Substances 0.000 claims description 84
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 82
- 230000008859 change Effects 0.000 claims description 69
- 108010054147 Hemoglobins Proteins 0.000 claims description 49
- 102000001554 Hemoglobins Human genes 0.000 claims description 49
- 230000002706 hydrostatic effect Effects 0.000 claims description 29
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 11
- 239000008103 glucose Substances 0.000 claims description 11
- 230000001939 inductive effect Effects 0.000 claims description 10
- 238000011481 absorbance measurement Methods 0.000 claims description 9
- 239000012491 analyte Substances 0.000 claims description 8
- 230000001934 delay Effects 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 3
- 230000003028 elevating effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 17
- 238000005259 measurement Methods 0.000 description 60
- 210000003811 finger Anatomy 0.000 description 34
- 210000003371 toe Anatomy 0.000 description 19
- 230000008033 biological extinction Effects 0.000 description 15
- 210000001367 artery Anatomy 0.000 description 14
- 210000003414 extremity Anatomy 0.000 description 14
- 230000033001 locomotion Effects 0.000 description 14
- 210000004072 lung Anatomy 0.000 description 14
- 238000000862 absorption spectrum Methods 0.000 description 12
- 230000008569 process Effects 0.000 description 12
- 108010003320 Carboxyhemoglobin Proteins 0.000 description 11
- 108010061951 Methemoglobin Proteins 0.000 description 11
- 210000002683 foot Anatomy 0.000 description 11
- 108010064719 Oxyhemoglobins Proteins 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 230000017531 blood circulation Effects 0.000 description 10
- 230000036541 health Effects 0.000 description 10
- 210000005240 left ventricle Anatomy 0.000 description 10
- 238000004364 calculation method Methods 0.000 description 9
- 230000007423 decrease Effects 0.000 description 9
- 238000003745 diagnosis Methods 0.000 description 9
- 210000004247 hand Anatomy 0.000 description 9
- 210000000056 organ Anatomy 0.000 description 9
- 238000002106 pulse oximetry Methods 0.000 description 9
- INGWEZCOABYORO-UHFFFAOYSA-N 2-(furan-2-yl)-7-methyl-1h-1,8-naphthyridin-4-one Chemical compound N=1C2=NC(C)=CC=C2C(O)=CC=1C1=CC=CO1 INGWEZCOABYORO-UHFFFAOYSA-N 0.000 description 8
- 210000000709 aorta Anatomy 0.000 description 8
- 235000013405 beer Nutrition 0.000 description 8
- 210000000038 chest Anatomy 0.000 description 8
- 108010002255 deoxyhemoglobin Proteins 0.000 description 8
- 230000000541 pulsatile effect Effects 0.000 description 8
- 210000003462 vein Anatomy 0.000 description 8
- 230000004872 arterial blood pressure Effects 0.000 description 7
- 230000036961 partial effect Effects 0.000 description 7
- 230000002093 peripheral effect Effects 0.000 description 7
- 208000018262 Peripheral vascular disease Diseases 0.000 description 6
- 239000006096 absorbing agent Substances 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 206010003119 arrhythmia Diseases 0.000 description 6
- 238000004422 calculation algorithm Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000006698 induction Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000029058 respiratory gaseous exchange Effects 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical group [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 210000001715 carotid artery Anatomy 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 230000002526 effect on cardiovascular system Effects 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 210000003141 lower extremity Anatomy 0.000 description 5
- 230000036387 respiratory rate Effects 0.000 description 5
- 210000003270 subclavian artery Anatomy 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 5
- 206010006322 Breath holding Diseases 0.000 description 4
- 230000001133 acceleration Effects 0.000 description 4
- 238000009530 blood pressure measurement Methods 0.000 description 4
- 230000036770 blood supply Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000010494 dissociation reaction Methods 0.000 description 4
- 230000005593 dissociations Effects 0.000 description 4
- 210000003128 head Anatomy 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 238000002798 spectrophotometry method Methods 0.000 description 4
- 238000013494 PH determination Methods 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 210000002376 aorta thoracic Anatomy 0.000 description 3
- 230000002567 autonomic effect Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 206010010121 compartment syndrome Diseases 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 210000005069 ears Anatomy 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000000474 nursing effect Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 210000005241 right ventricle Anatomy 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000002861 ventricular Effects 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 208000006179 Aortic Coarctation Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010009807 Coarctation of the aorta Diseases 0.000 description 2
- 208000028399 Critical Illness Diseases 0.000 description 2
- 108010044495 Fetal Hemoglobin Proteins 0.000 description 2
- 108010085682 Hemoglobin A Proteins 0.000 description 2
- 102000007513 Hemoglobin A Human genes 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 238000002399 angioplasty Methods 0.000 description 2
- 108010000865 aquomethemoglobin Proteins 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 210000002565 arteriole Anatomy 0.000 description 2
- 230000001746 atrial effect Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000002302 brachial artery Anatomy 0.000 description 2
- 210000002168 brachiocephalic trunk Anatomy 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000013480 data collection Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 210000005246 left atrium Anatomy 0.000 description 2
- 239000002906 medical waste Substances 0.000 description 2
- 238000002496 oximetry Methods 0.000 description 2
- 238000006213 oxygenation reaction Methods 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 210000005245 right atrium Anatomy 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 210000001364 upper extremity Anatomy 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- 210000000264 venule Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 101100243025 Arabidopsis thaliana PCO2 gene Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 208000002330 Congenital Heart Defects Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 208000023281 Fallot tetralogy Diseases 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010058558 Hypoperfusion Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 208000035478 Interatrial communication Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000007542 Paresis Diseases 0.000 description 1
- 208000004605 Persistent Truncus Arteriosus Diseases 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 201000003005 Tetralogy of Fallot Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010044443 Transposition of the great vessels Diseases 0.000 description 1
- 208000037258 Truncus arteriosus Diseases 0.000 description 1
- 208000001910 Ventricular Heart Septal Defects Diseases 0.000 description 1
- 206010047281 Ventricular arrhythmia Diseases 0.000 description 1
- HGARVTAFZZBPMQ-BLPRJPCASA-N [C@@H]1([C@H](O)[C@H](OP(=O)(O)O)[C@@H](COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O1)N1C=NC=2C(N)=NC=NC12.C(=O)=O Chemical compound [C@@H]1([C@H](O)[C@H](OP(=O)(O)O)[C@@H](COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O1)N1C=NC=2C(N)=NC=NC12.C(=O)=O HGARVTAFZZBPMQ-BLPRJPCASA-N 0.000 description 1
- 208000002223 abdominal aortic aneurysm Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 208000007474 aortic aneurysm Diseases 0.000 description 1
- 208000013914 atrial heart septal defect Diseases 0.000 description 1
- 206010003664 atrial septal defect Diseases 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 238000002555 auscultation Methods 0.000 description 1
- 230000010455 autoregulation Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 208000006170 carotid stenosis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 208000028831 congenital heart disease Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 238000002565 electrocardiography Methods 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 238000001362 electron spin resonance spectrum Methods 0.000 description 1
- 238000002692 epidural anesthesia Methods 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 238000002683 hand surgery Methods 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000009532 heart rate measurement Methods 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000000870 hyperventilation Effects 0.000 description 1
- 208000000122 hyperventilation Diseases 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 210000003090 iliac artery Anatomy 0.000 description 1
- 238000012623 in vivo measurement Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000007620 mathematical function Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000005541 medical transmission Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000005486 microgravity Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- -1 nitrogen Chemical compound 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000002640 oxygen therapy Methods 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 208000012318 pareses Diseases 0.000 description 1
- 208000003278 patent ductus arteriosus Diseases 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 210000003492 pulmonary vein Anatomy 0.000 description 1
- 230000035485 pulse pressure Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008672 reprogramming Effects 0.000 description 1
- 230000004202 respiratory function Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000002693 spinal anesthesia Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 210000002820 sympathetic nervous system Anatomy 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 208000014903 transposition of the great arteries Diseases 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 201000003130 ventricular septal defect Diseases 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 230000021542 voluntary musculoskeletal movement Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6825—Hand
- A61B5/6826—Finger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/02028—Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B5/02055—Simultaneously evaluating both cardiovascular condition and temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14539—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring pH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4821—Determining level or depth of anaesthesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/683—Means for maintaining contact with the body
- A61B5/6838—Clamps or clips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0242—Operational features adapted to measure environmental factors, e.g. temperature, pollution
- A61B2560/0247—Operational features adapted to measure environmental factors, e.g. temperature, pollution for compensation or correction of the measured physiological value
- A61B2560/0261—Operational features adapted to measure environmental factors, e.g. temperature, pollution for compensation or correction of the measured physiological value using hydrostatic pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02416—Detecting, measuring or recording pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/026—Measuring blood flow
- A61B5/0285—Measuring or recording phase velocity of blood waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/026—Measuring blood flow
- A61B5/029—Measuring or recording blood output from the heart, e.g. minute volume
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14552—Details of sensors specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/369—Electroencephalography [EEG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/389—Electromyography [EMG]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Physiology (AREA)
- Optics & Photonics (AREA)
- Anesthesiology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Abstract
L'invention concerne des méthodes permettant de contrôler, de façon non invasive, des caractéristiques physiologiques du sang d'un patient. Pour déterminer la concentration des constituants sanguins, il suffit de comparer l'absorbance du rayonnement avec différents paramètres, tels que la longueur du trajet optique et la pression sanguine. Pour faire varier la pression, il suffit de modifier la hauteur des sondes par rapport au coeur du patient. Pour déterminer le pH sanguin, il suffit de comparer l'absorbance du sang avec différentes longueurs d'ondes. Ces méthodes permettent également de déterminer avec précision la température du sang et, par conséquent, la température centrale du patient. Les méthodes de l'invention permettent également de déterminer, de façon non invasive, des caractéristiques du débit cardiaque et de la pression sanguine.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2001/046855 WO2003039326A2 (fr) | 2001-11-07 | 2001-11-07 | Methode de determination en continu et de façon non invasive des caracteristiques physiologiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2466012A1 true CA2466012A1 (fr) | 2003-05-15 |
Family
ID=21743081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002466012A Abandoned CA2466012A1 (fr) | 2001-11-07 | 2001-11-07 | Methode de determination en continu et de facon non invasive des caracteristiques physiologiques |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1450672A4 (fr) |
| JP (1) | JP2005507298A (fr) |
| AU (1) | AU2001297917B2 (fr) |
| CA (1) | CA2466012A1 (fr) |
| MX (1) | MXPA04004286A (fr) |
| WO (1) | WO2003039326A2 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220265158A1 (en) * | 2019-08-08 | 2022-08-25 | Nippon Telegraph And Telephone Corporation | Sphygmomanometer |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8932227B2 (en) | 2000-07-28 | 2015-01-13 | Lawrence A. Lynn | System and method for CO2 and oximetry integration |
| US9468378B2 (en) | 1997-01-27 | 2016-10-18 | Lawrence A. Lynn | Airway instability detection system and method |
| US9042952B2 (en) | 1997-01-27 | 2015-05-26 | Lawrence A. Lynn | System and method for automatic detection of a plurality of SPO2 time series pattern types |
| US9521971B2 (en) | 1997-07-14 | 2016-12-20 | Lawrence A. Lynn | System and method for automatic detection of a plurality of SPO2 time series pattern types |
| US9053222B2 (en) | 2002-05-17 | 2015-06-09 | Lawrence A. Lynn | Patient safety processor |
| US20060195041A1 (en) | 2002-05-17 | 2006-08-31 | Lynn Lawrence A | Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions |
| GB0213836D0 (en) * | 2002-06-14 | 2002-07-24 | Electrode Company The Ltd | Analytical apparatus |
| KR100624412B1 (ko) * | 2003-09-16 | 2006-09-18 | 삼성전자주식회사 | 혈중성분 측정장치 및 이를 이용한 혈중성분측정방법 |
| JP2006231012A (ja) * | 2005-01-28 | 2006-09-07 | Nippon Koden Corp | 酸素運搬の循環時間測定方法および装置 |
| US7674231B2 (en) | 2005-08-22 | 2010-03-09 | Massachusetts Institute Of Technology | Wearable pulse wave velocity blood pressure sensor and methods of calibration thereof |
| US7641614B2 (en) | 2005-08-22 | 2010-01-05 | Massachusetts Institute Of Technology | Wearable blood pressure sensor and method of calibration |
| US7904130B2 (en) | 2005-09-29 | 2011-03-08 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
| US7869850B2 (en) | 2005-09-29 | 2011-01-11 | Nellcor Puritan Bennett Llc | Medical sensor for reducing motion artifacts and technique for using the same |
| US8219170B2 (en) | 2006-09-20 | 2012-07-10 | Nellcor Puritan Bennett Llc | System and method for practicing spectrophotometry using light emitting nanostructure devices |
| US7574245B2 (en) | 2006-09-27 | 2009-08-11 | Nellcor Puritan Bennett Llc | Flexible medical sensor enclosure |
| US7684842B2 (en) | 2006-09-29 | 2010-03-23 | Nellcor Puritan Bennett Llc | System and method for preventing sensor misuse |
| ITMI20070464A1 (it) * | 2007-03-09 | 2008-09-10 | Vittorio Londoni | Dispositivo laser diodico per la determinazione incruenta della glicemia |
| US8265724B2 (en) | 2007-03-09 | 2012-09-11 | Nellcor Puritan Bennett Llc | Cancellation of light shunting |
| US8280469B2 (en) | 2007-03-09 | 2012-10-02 | Nellcor Puritan Bennett Llc | Method for detection of aberrant tissue spectra |
| US8750953B2 (en) | 2008-02-19 | 2014-06-10 | Covidien Lp | Methods and systems for alerting practitioners to physiological conditions |
| WO2009137682A1 (fr) | 2008-05-07 | 2009-11-12 | Lynn Lawrence A | Moteur de recherche de modèle d’échec médical |
| US8295567B2 (en) | 2008-06-30 | 2012-10-23 | Nellcor Puritan Bennett Ireland | Systems and methods for ridge selection in scalograms of signals |
| US9895068B2 (en) | 2008-06-30 | 2018-02-20 | Covidien Lp | Pulse oximeter with wait-time indication |
| US8968193B2 (en) | 2008-09-30 | 2015-03-03 | Covidien Lp | System and method for enabling a research mode on physiological monitors |
| EP2348959B1 (fr) | 2008-10-31 | 2018-09-19 | Covidien LP | Système pour faciliter l'observation de données physiologiques monitorées |
| US8313439B2 (en) | 2009-03-20 | 2012-11-20 | Massachusetts Institute Of Technology | Calibration of pulse transit time measurements to arterial blood pressure using external arterial pressure applied along the pulse transit path |
| EP2498675A1 (fr) * | 2009-11-12 | 2012-09-19 | Nellcor Puritan Bennett LLC | Systèmes et procédés pour capteurs physiologiques combinés |
| JP5302257B2 (ja) * | 2010-04-05 | 2013-10-02 | 建夫 斎藤 | 組織血流量測定装置及び組織血流量測定用プログラム |
| CN101799412B (zh) * | 2010-04-07 | 2012-04-25 | 中国科学院自动化研究所 | 无创测量人体血糖的近红外光谱透射方法及装置 |
| US8610769B2 (en) | 2011-02-28 | 2013-12-17 | Covidien Lp | Medical monitor data collection system and method |
| EP2502555A1 (fr) * | 2011-03-22 | 2012-09-26 | Bmeye B.V. | Système de mesure de distribution d'oxygène non invasive et procédé |
| WO2013113055A1 (fr) * | 2012-01-30 | 2013-08-08 | Campbell Duncan Islay | Procédé et appareil de détermination non invasive du débit cardiaque |
| US8880155B2 (en) | 2012-02-24 | 2014-11-04 | Covidien Lp | Hypovolemia diagnosis technique |
| US11399898B2 (en) | 2012-03-06 | 2022-08-02 | Briteseed, Llc | User interface for a system used to determine tissue or artifact characteristics |
| US9693697B2 (en) | 2012-03-29 | 2017-07-04 | Benny Tal | Hand-held device having health monitoring capabilities |
| CN103505190B (zh) * | 2012-06-18 | 2015-02-25 | 美盛医电股份有限公司 | 测量装置 |
| US10827961B1 (en) | 2012-08-29 | 2020-11-10 | Masimo Corporation | Physiological measurement calibration |
| US9241646B2 (en) | 2012-09-11 | 2016-01-26 | Covidien Lp | System and method for determining stroke volume of a patient |
| JP6055688B2 (ja) | 2013-01-31 | 2016-12-27 | 日本光電工業株式会社 | 生体信号測定システム、生体信号測定装置、および生体信号測定装置の制御プログラム |
| US20160029973A1 (en) * | 2013-06-13 | 2016-02-04 | Koninklijke Philips N.V. | Device and method for determining a partial carbon dioxide pressure in a subject of interest |
| JP6511471B2 (ja) | 2014-03-25 | 2019-05-15 | ブライトシード・エルエルシーＢｒｉｔｅｓｅｅｄ，Ｌｌｃ | 脈管検出器及び検出方法 |
| US10820838B2 (en) | 2015-02-19 | 2020-11-03 | Briteseed, Llc | System for determining vessel size using light absorption |
| EP3545830B1 (fr) | 2015-02-19 | 2022-01-05 | Briteseed, LLC | Système pour déterminer le bord d'un vaisseau |
| JP7057277B2 (ja) | 2015-10-08 | 2022-04-19 | ブライトシード・エルエルシー | 脈管サイズを決定するシステム及びその方法 |
| ES2969019T3 (es) | 2016-02-12 | 2024-05-16 | Briteseed Llc | Determinación de la presencia de un vaso dentro de una región próxima a un extremo de trabajo de un instrumento quirúrgico |
| DE102016109694A1 (de) * | 2016-05-25 | 2017-11-30 | Osram Opto Semiconductors Gmbh | Sensorvorrichtung |
| EP4026489A1 (fr) | 2016-08-30 | 2022-07-13 | Briteseed, LLC | Système et procédé permettant de déterminer la taille de vaisseau avec une compensation de distorsion angulaire |
| WO2018094243A1 (fr) * | 2016-11-17 | 2018-05-24 | Medici Technologies, LLC | Enceinte de membre sous pression auto-étanche |
| WO2019050928A1 (fr) | 2017-09-05 | 2019-03-14 | Briteseed, Llc | Système et procédé utilisés pour déterminer des caractéristiques de tissu et/ou d'artéfact |
| JP7313353B2 (ja) | 2017-12-22 | 2023-07-24 | ブライトシード・エルエルシー | 組織又はアーチファクト特性を決定するために使用される小型システム |
| EP3902471B1 (fr) | 2018-12-30 | 2024-09-18 | Briteseed, LLC | Système utilisé pour détecter ou différencier un tissu ou un artefact |
| BR112021016857A2 (pt) * | 2019-02-26 | 2021-10-19 | Digital Blood Corporation | Sistema para exame não invasivo de parâmetros de ambiente sanguíneo de um usuário |
| WO2022016103A1 (fr) * | 2020-07-17 | 2022-01-20 | Board Of Trustees Of Michigan State University | Techniques de criblage et de surveillance de patients pour des anévrismes de l'aorte |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4968137A (en) * | 1986-12-05 | 1990-11-06 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon Health Sciences University | Devices and procedures for in vitro testing of pulse oximetry monitors |
| US5372136A (en) * | 1990-10-06 | 1994-12-13 | Noninvasive Medical Technology Corporation | System and method for noninvasive hematocrit monitoring |
| JP3116252B2 (ja) * | 1992-07-09 | 2000-12-11 | 日本光電工業株式会社 | パルスオキシメータ |
| US6222189B1 (en) * | 1992-07-15 | 2001-04-24 | Optix, Lp | Methods of enhancing optical signals by mechanical manipulation in non-invasive testing |
| US5638816A (en) * | 1995-06-07 | 1997-06-17 | Masimo Corporation | Active pulse blood constituent monitoring |
| EP0944347B1 (fr) * | 1996-07-19 | 2006-11-29 | Daedalus I, LLC | Dispositif non invasif de calcul de parametres du sang |
| JP3856477B2 (ja) * | 1996-10-24 | 2006-12-13 | マサチューセッツ・インスティテュート・オブ・テクノロジー | 患者監視指輪センサ |
| ATE521277T1 (de) * | 1998-06-03 | 2011-09-15 | Masimo Corp | Stereo puls oximeter |
| EP1233697A4 (fr) * | 1999-10-07 | 2005-06-22 | Alexander K Mills | Procede non invasif de determination en continu de caracteristiques physiologiques et dispositif a cet effet |
-
2001
- 2001-11-07 CA CA002466012A patent/CA2466012A1/fr not_active Abandoned
- 2001-11-07 MX MXPA04004286A patent/MXPA04004286A/es active IP Right Grant
- 2001-11-07 EP EP01274207A patent/EP1450672A4/fr not_active Withdrawn
- 2001-11-07 WO PCT/US2001/046855 patent/WO2003039326A2/fr active Application Filing
- 2001-11-07 JP JP2003541424A patent/JP2005507298A/ja active Pending
- 2001-11-07 AU AU2001297917A patent/AU2001297917B2/en not_active Ceased
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220265158A1 (en) * | 2019-08-08 | 2022-08-25 | Nippon Telegraph And Telephone Corporation | Sphygmomanometer |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003039326A2 (fr) | 2003-05-15 |
| AU2001297917B2 (en) | 2007-11-01 |
| WO2003039326A8 (fr) | 2007-09-07 |
| AU2001297917A1 (en) | 2003-05-19 |
| EP1450672A4 (fr) | 2005-06-22 |
| EP1450672A2 (fr) | 2004-09-01 |
| WO2003039326A3 (fr) | 2003-07-24 |
| MXPA04004286A (es) | 2004-09-10 |
| JP2005507298A (ja) | 2005-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6819950B2 (en) | Method for noninvasive continuous determination of physiologic characteristics | |
| AU2001297917B2 (en) | Method for noninvasive continuous determination of physiologic characteristics | |
| AU766952B2 (en) | Device and method for noninvasive continuous determination of physiologic characteristics | |
| EP1469773B1 (fr) | Oxymetrie pulsee pour mesurer la saturation veineuse en oxygene | |
| EP1601287B1 (fr) | Evaluation d'une réduction du volume sanguin sur la base de l'analyse de signaux cardiovasculaires | |
| JP5645655B2 (ja) | 血中酸素飽和度の非侵襲的測定 | |
| US7044917B2 (en) | Method and apparatus for measuring pulsus paradoxus | |
| Yoon et al. | Nonconstrained blood pressure measurement by photoplethysmography | |
| EP1332713A1 (fr) | Oxymetrie veineuse pulsee | |
| JP6726171B2 (ja) | 胸骨から生理パラメータを測定する方法 | |
| Budidha | In vivo investigations of photoplethysmograms and arterial oxygen saturation from the auditory canal in conditions of compromised peripheral perfusion | |
| Chan | Non-invasive venous oximetry through venous blood volume modulation | |
| Cloete | Non-invasive artificial pulse oximetry: development & testing | |
| Katan et al. | Self-calibrated biosensor for measuring multiple physiological parameters | |
| Subramanian | Real time perfusion and oxygenation monitoring in an implantable optical sensor | |
| Aniagyei-Mensah | Noninvasive Detection of Central Venous Waveform Using Photoplethysmography | |
| Abu Shokor et al. | Design of a Wearable Device for Noninvasive Cardiovascular Measurements (SPO2, heart rate and blood pressure) | |
| COSTAŞ et al. | SOME CONSIDERATION ABOUT ELECTROMEDICAL DEVICES IMPLEMENTATION IN HUMAN BEHAVIOR ANALYZE | |
| Mould | C zyxwvutsrqponmlkjihg | |
| Wolf | The measurement of the oxygenation status of the newborn infant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |